United States biotech business Spero Rehabs scraps prospect after stopped working Stage II test.
发布者：BY ALBERT RONNING-ANDERSSON，转转请注明出处：https://robotalks.cn/spero-therapeutics-fails-midway-reduces-workforce-by-39/
Spero Therapeutics fails midway – reduces workforce by 39%
赞 (0)
关于作者
New biotech company aims to commercialize research in bottled exercise
上一篇
3 11 月, 2024 2:20 下午
Boehringer Ingelheim stops development of Gubra obesity drug
下一篇
3 11 月, 2024 2:20 下午
相关推荐
-
Archer Aviation Showcases Midnight Aircraft in Atlanta, “Manufacturing Facility in Georgia Nears Completion”
Archer Aeronautics revealed today 2 most current items of information, reports a news release. Its Covington, Georgia producing center is close to conclusion and to prepare, the eV…
-
Vicinity Motor launches its first automated transit bus at Sleeping Bear national park
Area Electric motor, a North American provider of business electrical automobiles, has actually introduced its very first public implementation of a Location Autonomous Lightning E…
-
Australia’s coal production to grow 2.8% in 2024 but fall towards 2030
Australian coal miners are dealing with price inflation pressures, together with greater labour, gasoline and distribution prices. The publish Australia’s coal production to grow 2…
-
Grocery Chain Kroger to Ramp Up Automation at Distribution Centers
Kroger strategies to utilize Ocado’s robot choosing arms to relocate grocery stores off of close-by racks right into bags for on the internet consumer orders.
-
How Ergonomic Mobile Workstations Boost Warehouse Worker Satisfaction in 2024
Enhance Storehouse Employee Contentment and Performance with Ergonomic Solutions and Fair Payment: Insights from the 2024 Newcastle Solutions Study.
